Scott Fidel
Stock Analyst at Stephens & Co.
(4.14)
# 544
Out of 4,761 analysts
177
Total ratings
66.06%
Success rate
8.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $13.18 | +28.98% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $57.68 | +26.56% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $466.42 | +44.72% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $12.79 | +142.38% | 4 | Nov 18, 2024 | |
| ADUS Addus HomeCare | Maintains: Overweight | $143 → $145 | $109.23 | +32.75% | 11 | Nov 6, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $299.81 | +36.75% | 12 | Nov 1, 2024 | |
| ENSG The Ensign Group | Maintains: Overweight | $163 → $167 | $126.34 | +32.18% | 9 | Oct 28, 2024 | |
| GRDN Guardian Pharmacy Services | Initiates: Overweight | $21 | $19.58 | +7.25% | 1 | Oct 22, 2024 | |
| HUM Humana | Reiterates: Equal-Weight | $250 | $255.91 | -2.31% | 7 | Oct 9, 2024 | |
| PNTG The Pennant Group | Reiterates: Overweight | $40 | $25.05 | +59.68% | 17 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $24 | $13.90 | +72.66% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $385.10 | +59.70% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $97.53 | +7.66% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $283.81 | +12.75% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $200 | $180.03 | +11.09% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $129.60 | -5.86% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $39.65 | +132.03% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $316.42 | -11.51% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $5.05 | +1,781.19% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $103 | $90.44 | +13.89% | 12 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $4.23 | -64.54% | 3 | Nov 11, 2022 |
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $13.18
Upside: +28.98%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $57.68
Upside: +26.56%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $466.42
Upside: +44.72%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $12.79
Upside: +142.38%
Addus HomeCare
Nov 6, 2024
Maintains: Overweight
Price Target: $143 → $145
Current: $109.23
Upside: +32.75%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $299.81
Upside: +36.75%
The Ensign Group
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $126.34
Upside: +32.18%
Guardian Pharmacy Services
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $19.58
Upside: +7.25%
Humana
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $255.91
Upside: -2.31%
The Pennant Group
Oct 9, 2024
Reiterates: Overweight
Price Target: $40
Current: $25.05
Upside: +59.68%
Sep 19, 2024
Reiterates: Overweight
Price Target: $24
Current: $13.90
Upside: +72.66%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $385.10
Upside: +59.70%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $97.53
Upside: +7.66%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $283.81
Upside: +12.75%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $200
Current: $180.03
Upside: +11.09%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $129.60
Upside: -5.86%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $39.65
Upside: +132.03%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $316.42
Upside: -11.51%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $5.05
Upside: +1,781.19%
May 4, 2023
Reiterates: Equal-Weight
Price Target: $103
Current: $90.44
Upside: +13.89%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $4.23
Upside: -64.54%